| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |